HKSE - Delayed Quote HKD
JD Health International Inc. (6618.HK)
38.850
-1.100
(-2.75%)
As of 3:23:53 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
58,159,881
58,159,881
53,529,941
46,736,150
30,682,267
Cost of Revenue
44,851,304
44,851,304
41,664,605
36,844,642
23,484,985
Gross Profit
13,308,577
13,308,577
11,865,336
9,891,508
7,197,282
Operating Expense
11,829,813
11,829,813
11,164,629
9,938,426
8,562,975
Operating Income
1,478,764
1,478,764
700,707
-46,918
-1,365,693
Net Non Operating Interest Income Expense
1,952,308
1,952,308
1,939,547
855,167
451,570
Pretax Income
4,796,676
4,796,676
2,693,348
695,809
-901,491
Tax Provision
639,662
639,662
550,468
312,580
171,327
Net Income Common Stockholders
4,161,844
4,161,844
2,141,841
380,105
-1,073,507
Diluted NI Available to Com Stockholders
4,161,844
4,161,844
2,141,841
380,105
-1,073,507
Basic EPS
0.84
1.32
0.69
0.12
-0.35
Diluted EPS
0.84
1.32
0.68
0.12
-0.35
Basic Average Shares
3,133,569
3,142,727
3,123,736
3,106,937
3,094,893
Diluted Average Shares
3,160,579.500
3,160,278
3,163,985
3,144,376
3,094,893
Total Expenses
56,681,117
56,681,117
52,829,234
46,783,068
32,047,960
Net Income from Continuing & Discontinued Operation
4,161,844
4,161,844
2,141,841
380,105
-1,073,507
Normalized Income
4,435,576.339
4,435,576.339
2,197,422.178
453,756.500
-1,044,743
Interest Income
1,960,502
1,960,502
1,949,032
864,266
457,569
Interest Expense
8,194
8,194
9,485
9,099
5,999
Net Interest Income
1,952,308
1,952,308
1,939,547
855,167
451,570
EBIT
4,804,870
4,804,870
2,702,833
704,908
-895,492
EBITDA
5,019,565
5,019,565
2,930,291
845,584
-832,323
Reconciled Cost of Revenue
44,851,304
44,851,304
41,664,605
36,844,642
23,484,985
Reconciled Depreciation
214,695
214,695
227,458
140,676
63,169
Net Income from Continuing Operation Net Minority Interest
4,161,844
4,161,844
2,141,841
380,105
-1,073,507
Total Unusual Items Excluding Goodwill
-315,853
-315,853
-69,859
-98,202
-38,352
Total Unusual Items
-315,853
-315,853
-69,859
-98,202
-38,352
Normalized EBITDA
5,335,418
5,335,418
3,000,150
943,786
-793,971
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-42,120.661
-42,120.661
-14,277.822
-24,550.500
-9,588
12/31/2021 - 12/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade